Related Experiment Videos
Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation
T M Bianco1, H I Bussey, L E Farnett
1Department of Pharmacology, University of Texas Health Science Center, San Antonio.
Pharmacotherapy
|January 1, 1992
Summary
This study found that the antibiotic ciprofloxacin does not significantly interact with warfarin, a common blood thinner. Patients taking both medications did not experience increased bleeding risks.
Area of Science:
- Pharmacology
- Infectious Diseases
- Cardiology
Background:
- Warfarin is a widely prescribed oral anticoagulant.
- Quinolone antimicrobials, such as ciprofloxacin, are frequently used to treat infections.
- Potential drug interactions between warfarin and other medications require thorough investigation.
Purpose of the Study:
- To prospectively evaluate the potential drug interaction between warfarin and ciprofloxacin.
- To assess the effect of ciprofloxacin on the anticoagulant activity of warfarin.
Main Methods:
- A randomized, placebo-controlled study design was employed.
- 16 patients on stable warfarin therapy were included.
- Patients received either ciprofloxacin (500 mg twice daily) or placebo for 10 days after a 10-day placebo lead-in.
- International Normalized Ratios (INRs) were monitored using standard laboratory and finger-stick methods.
Main Results:
- No significant increase in INR was observed in patients receiving ciprofloxacin concurrently with warfarin.
- No bleeding events were reported in any study participant.
- Both standard laboratory and finger-stick INR measurements showed consistent results.
Conclusions:
- Ciprofloxacin, at a dosage of 500 mg twice daily for 10 days, does not appear to cause a clinically significant interaction with warfarin.
- The concurrent use of warfarin and ciprofloxacin is likely safe under these specific conditions.
- Further research may explore interactions with different dosages or durations of ciprofloxacin therapy.